Dulac Edward J III

CIK 00018215302 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001821530

Recent Transactions

36 trades

Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2026-01-05$9.21/sh−6,379→ 99,683 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-07-23$14.02/sh−7,462→ 106,062 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2025-03-01+67,429→ 67,429 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-03-01+47,200→ 113,524 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-07-22+66,324→ 66,324 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2024-07-22+96,219→ 96,219 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2024-03-04$7.77/sh−2,447→ 101,479 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2024-02-01+425,000→ 425,000 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2024-01-29$5.00/sh−1,849→ 103,926 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2024-01-09$4.37/sh−7,028→ 105,775 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2024-01-02$3.66/sh−5,182→ 112,803 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2023-12-18$3.50/sh−1,585→ 117,985 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2023-08-18$2.80/sh−4,718→ 119,570 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2023-07-05$4.83/sh−5,182→ 124,288 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2023-02-06+425,000→ 425,000 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2023-01-10$5.24/sh−7,331→ 129,470 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-08-18$29.75/sh−4,703→ 137,233 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-08-18$30.41/sh−432→ 136,801 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2022-01-25+53,058→ 53,058 total
Award
FATE THERAPEUTICS INC$FATE
Common Stock
2022-01-25+33,302→ 141,936 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-01-11$48.25/sh−1,380→ 109,024 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-01-11$49.16/sh−390→ 108,634 total
Exercise/Conversion
FATE THERAPEUTICS INC$FATE
Common Stock
2021-12-20$35.52/sh+14,437→ 126,381 total
Exercise/Conversion
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2021-12-20−14,437→ 128,238 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2021-12-20$60.00/sh−15,977→ 110,404 total
Award
FATE THERAPEUTICS INC$FATE
Common Stock
2021-11-19+59,540→ 111,944 total
Exercise/Conversion
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2021-09-28−17,325→ 142,675 total
Exercise/Conversion
FATE THERAPEUTICS INC$FATE
Common Stock
2021-09-28$35.52/sh+17,325→ 71,864 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2021-09-28$62.53/sh−19,460→ 52,404 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2021-08-19$88.65/sh−1,474→ 54,602 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2021-08-19$87.90/sh−1,937→ 56,076 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2021-08-19$90.00/sh−63→ 54,539 total
Award
FATE THERAPEUTICS INC$FATE
Common stock
2021-01-20+18,013→ 58,013 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (right to buy)
2021-01-20+6,851→ 6,851 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (right to buy)
2020-08-17+160,000→ 160,000 total
Award
FATE THERAPEUTICS INC$FATE
Common stock
2020-08-17+40,000→ 40,000 total

Companies

Recent Filings

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET, SUITE 130

CAMBRIDGE, MA, 02139

View on SEC.gov